Moore Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,096
Closed -$2.31M 728
2025
Q4
$2.31M Buy
+25,096
New +$2.4M 0.03% 357
2023
Q2
Sell
-11,291
Closed -$2.64M 553
2023
Q1
$2.64M Sell
11,291
-8,709
-44% -$2.2M 0.06% 215
2022
Q4
$5.04M Sell
20,000
-79,034
-80% -$16.9M 0.12% 159
2022
Q3
$17.6M Buy
99,034
+25,098
+34% +$5.04M 0.41% 45
2022
Q2
$13.5M Buy
+73,936
New +$14.7M 0.36% 53
2022
Q1
Sell
-54,167
Closed -$12.5M 800
2021
Q4
$12.5M Sell
54,167
-23,638
-30% -$5.77M 0.25% 84
2021
Q3
$18.1M Buy
+77,805
New +$16.2M 0.28% 76

Other funds holding INSP

Moore Capital Management's INSP Position: Q1 2026 in Review

Moore Capital Management sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 25,096 shares — an estimated $2.31M sold.

Moore Capital Management first reported a position in INSP in Q3 2021 and held it in 7 quarters. The position peaked at $18.1M in Q3 2021. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Moore Capital Management reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Moore Capital Management sold 25,096 Inspire Medical Systems shares in Q1 2026, an estimated $2.31M.
  • Moore Capital Management first reported a position in Inspire Medical Systems in Q3 2021 and held it in 7 quarters.
  • Moore Capital Management's Inspire Medical Systems position peaked at $18.1M in Q3 2021.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.